Advertisement
Screener

ENTERA BIO LTD. (ENTX) ROA

ENTERA BIO LTD. (ENTX) ROA

  • 2026-06-30: ROA -87.44%.
  • 2026-03-31: ROA -94.27%.
  • 2025-12-31: ROA -71.53%.
  • 2025-09-30: ROA -61.93%.

Complete source-backed roa history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-87.44%
2026-03-31-94.27%
2025-12-31-71.53%
2025-09-30-61.93%
2025-06-30-53.91%
2025-03-31-46.72%
2024-12-31-101.61%
2024-09-30-118.56%
2024-06-30-85.06%
2024-03-31-85.13%
2023-12-31-75.55%
2023-09-30-115.93%
2023-06-30-101.65%
2023-03-31-98.89%
2022-12-31-99.57%
2022-09-30-90.97%
2022-06-30-74.83%
2022-03-31-61.29%
2021-12-31-46.90%

Annual ROA

DateROA
2025-12-31-71.53%
2024-12-31-101.61%
2023-12-31-75.55%
2022-12-31-99.57%
2021-12-31-46.90%
2020-12-31-115.37%

Similar stocks

Stock NameCountryMarket CapPE Ratio
REGENXBIO Inc. (RGNX)United States$0.477B-3.30
Tectonic Therapeutic, Inc. (TECX)United States$0.469B-7.68
Autolus Therapeutics plc (AUTL)$0.506B-1.52
Eikon Therapeutics, Inc. (EIKN)United States$0.446B
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Prime Medicine, Inc. (PRME)United States$0.557B-3.54
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Zura Bio Ltd (ZURA)$0.398B-6.56
Allogene Therapeutics, Inc. (ALLO)United States$0.574B-4.33